Imperial Receives Recognition for Sustainability Performance!

Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Category:

Business Insights

    Business InsightsStudy Site Management

    Big News for Small Sites Seeking Research Grants, Part II

    by Stephanie Burns September 15, 2014
    written by Stephanie Burns

    – A Q&A on Government Research Grants –

    In the first segment of this two-part blog series, we heard from Johnna Medina (University of Texas, Austin), a fourth-year clinical psychology doctoral student, on her views and thoughts about clinical research at the university level and the process and struggles in obtaining government grant funding. While much of the process is similar for both graduate students and faculty/staff, the experiences and perspectives between the two groups can be much different. Today we will explore the topic of grant-funded research with Dr. Mark Powers, Research Associate Professor at the Anxiety & Health Behaviors Lab (University of Texas, Austin). Dr. Powers is conducting a five-year, NIDA-sponsored study of integrated PTSD and smoking cessation treatment.

    Q: What were your research goals before graduate school, and how have they changed over time? Has any of this been due to awareness or your experience obtaining grants/funding?

    A: I have always been interested in the nature, causes, and treatment of anxiety disorders. However, funding for research in anxiety disorders has decreased over time given how powerful many of the treatments are even though there is still room for growth. There is much more funding in the area of substance use disorders given that the standard treatments are generally less effective. Thus, from a funding perspective, my research is focused on a combination of anxiety disorders and substance use disorders.

    Q: How many grants did you apply to before receiving funding?  How do you feel this compares to other organizations?

    A: We apply for funding from the National Institutes of Health. The success rate is quite low. I had previously applied for about 14 before being awarded two grants.

    Q: What was your experience like trying to obtain funding for your study as a graduate student at a smaller university? How do you feel this compares to others attending or working at universities in general?

    A: My success/failure rate has been relatively steady at all of the various universities. I believe it may provide a more unique challenge at a very small or new university. However, for most of the relatively well-established universities this is usually not the primary factor.

    Q: What are the pros/cons to even having government-funded research in the first place?

    A: If one’s job does not depend on funding then what they study is far more open. If you need grant funding then you are at the mercy of where NIH wants to spend money.  If you are passionate about a specialized area that government research wouldn’t be interested in, then government-funded research obviously would not be considered a “pro.”

    Q: Don’t universities get blanket research funding from the government? Why would your study or program not automatically fall in that category?

    A: I am not personally aware of any such funding at my level.

    Q: Do you feel there is a bias in what type of research is funded? (Tell a little how it is selected).

    A: Yes. The NIH decides on what they want to focus on in funding grants. Currently the focus is on biological bases of mental disorders. Thus, if one wants to do, for example, a study on cognitive behavioral therapy, they would need to do so with biology in mind. This can be a challenge given that no biological causes of mental disorders are firmly understood.

    Q: We know that pharmaceutical research is generally heavily funded by the private sector, which can create bias (thus causing problems in the structure of research itself). How do you feel that this level of bias compares to that placed on what is funded through government grants?

    A: The purpose is different. Pharmaceutical companies are based on profit whereas government-funded projects are more geared toward the public good (as they see it). However, given the lack of biological mediators for mental disorders to date, “big pharma” is pulling out of central nervous system research and development.

    Q: For smaller sites, universities or individuals looking to obtain grant funding for their research, do you have any advice based upon your experiences?

    A: Yes, I would recommend checking with their targeted funding agencies and inquiring about funding priorities to help guide successful applications. Also, they can check what type of research is currently being funded as another indicator.

    Q: You have obtained grant funding for your research. Does this show promise for the future of those aiming to do the same, or what do you feel set you apart from the many who got rejected?

    A: Sure, someone once told me to be successful at grant writing you need to be OK with failure.

    Many in the research community are unaware of the struggles and processes that smaller sites and universities have to go through to fund their work.  It’s unfortunate that some may not be able to freely study what interests them most, but it is valuable information to keep in mind if one is considering a career in research. It is also interesting to think that what is being funded currently will heavily impact the future of science and medicine and, at the moment, our future shows promise of knowing more about the biological mechanisms and basis of mental disorders.

    September 15, 2014 0 comment
    0 FacebookTwitterLinkedinEmail
  • Business Insights

    3 Productivity Tools You Need Now

    by Kayden Grinwis September 2, 2014
    by Kayden Grinwis September 2, 2014

    Our revelation came about six months ago, thanks to a number of blog posts by Michael Hyatt. A colleague of mine was buzzing about the use of three separate yet integrated productivity tools to transform and organize our team. I thought he was nuts; ranting and raving about not one,…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsTranslation of Study Materials

    The Power of the Red Pen

    by Laurie Lindemeier August 22, 2014
    by Laurie Lindemeier August 22, 2014

    Proofreading in the Clinical Trials Industry Proofreading has taken on many forms over the centuries, from monks striving for accuracy as they hand-copied books by candlelight, to the modern-day English teacher’s red pen guiding students to improve their writing. I can recall as a college…

    0 FacebookTwitterLinkedinEmail
  • Business Insights

    See Do Get

    by Hope Cullen August 12, 2014
    by Hope Cullen August 12, 2014

    A simple strategy for effective organizational leadership In Stephen Covey’s book First Things First the author asserts that, “If we want to create significant change in the results, we can’t just change attitudes and behaviors, methods or techniques; we have to change the basic paradigms…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsStudy Site Management

    Big News for Small Sites Seeking Research Grants

    by Stephanie Burns August 6, 2014
    by Stephanie Burns August 6, 2014

    A Q&A with Johnna Medina, a clinical psychology doctoral student at the University of Texas, regarding government-funded research grants. Part I of II Who pays for clinical research? Nearly 75% of clinical trials are paid for by private companies, but where does the rest of…

    0 FacebookTwitterLinkedinEmail
  • Business Insights

    Into the Ocean with Only a Paddle

    by Hope Cullen July 18, 2014
    by Hope Cullen July 18, 2014

    The Steps of Continuous Improvement As I watched an episode of Aerial America regarding the Hawaiian Islands, I became fascinated with the story of the Polynesians who settled that land approximately 2000 years ago.  As I reflected on what a journey like that must have…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsPatient Recruitment and Retention

    Rural Clinical Trials: Something to Crow About

    by Laurie Lindemeier July 11, 2014
    by Laurie Lindemeier July 11, 2014

    As a young girl growing up on my family’s Minnesota dairy farm, my plastic ice cream pail held many types of eggs at the end of the day. One of my chores was to traipse all over our farm to scout out the location of…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsPatient Recruitment and RetentionStudy Site Management

    Only the Lean and Limber Need Apply

    by Melynda Geurts June 27, 2014
    by Melynda Geurts June 27, 2014

    Adaptive Clinical Trials: 6 Traits to Look for in a Vendor Adaptive is a word that has graced the life science industry for decades. By definition adaptive is showing or having a capacity for or tendency toward adaptation. Advancement of science through clinical trials is…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsTranslation of Study Materials

    Get to the Point! Communicating with Clarity

    by Felicia Fuller June 9, 2014
    by Felicia Fuller June 9, 2014

    5 Secrets to Communicating with Clarity As a writer, I love words for their ability to inform, inspire, illustrate, and evoke emotions. Yet few things irk me more than verbosity, whether written or spoken. How many times have you sought usable information from a presentation, article…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsLife-Science EventsPatient Recruitment and Retention

    Presentation Portion Control for Global Palates

    by Laurie Lindemeier May 30, 2014
    by Laurie Lindemeier May 30, 2014

    An interview with Melynda Geurts, VP of Operations at DAC “Slow down! Take it easy. Don’t bolt your food.” How often have you heard phrases like these? In the fast-pasted world of clinical trials, the “slow down” philosophy can be applied and achieve positive results…

    0 FacebookTwitterLinkedinEmail
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    The Upcoming FDA Clinical Trial Diversity Mandate: What You Need to Know

    May 14, 2025

Categories

  • Ancillary Trial Supplies and Equipment (34)
  • Business Insights (133)
  • Clinical Trial Writing and Design (40)
  • Life-Science Events (56)
  • Patient Engagement (39)
  • Patient Recruitment and Retention (99)
  • Site Materials & Logistics (50)
  • Study Site Management (22)
  • Translation of Study Materials (18)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.